<DOC>
	<DOC>NCT02962362</DOC>
	<brief_summary>The purpose of this study is to collect patient outcomes data for patients who are undergoing an Exactech Optetrak® primary total knee replacement using the Exactech Guided Personalized Surgery (eGPS®) manufactured or distributed by (Exactech, Gainesville, Florida, USA). Patient outcomes data are important for assessing the post-market safety and effectiveness of orthopedic medical devices.</brief_summary>
	<brief_title>eGPS® in Total Knee Arthroplasty</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Patient requires a primary Optetrak Logic Total Knee Arthroplasty Patient is skeletally mature with no obvious mechanical defect Patient is mentally capable of completing followup visits Patient is 18 years of age or greater at time of surgery Patient will be available for followup out to 2 years Patient has consented to participate in the clinical study Patient has a mental or physical condition that may invalidate evaluation of the data Patient is a prisoner Surgery is contraindicated according to the applicable product package insert Patient has a local or systemic infection Patient has a known sensitivity to one or more of the materials in the knee replacement system to be used Patient is pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>